1. Home
  2. ZVIA vs VRCA Comparison

ZVIA vs VRCA Comparison

Compare ZVIA & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevia PBC

ZVIA

Zevia PBC

HOLD

Current Price

$1.74

Market Cap

101.9M

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$6.10

Market Cap

117.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZVIA
VRCA
Founded
2007
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.9M
117.5M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
ZVIA
VRCA
Price
$1.74
$6.10
Analyst Decision
Buy
Buy
Analyst Count
4
2
Target Price
$4.93
$17.00
AVG Volume (30 Days)
1.5M
38.0K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
55.88
N/A
EPS
N/A
N/A
Revenue
$161,259,000.00
$35,577,000.00
Revenue This Year
$8.30
N/A
Revenue Next Year
$6.87
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
4.01
370.22
52 Week Low
$1.11
$0.70
52 Week High
$3.63
$9.82

Technical Indicators

Market Signals
Indicator
ZVIA
VRCA
Relative Strength Index (RSI) 63.33 50.79
Support Level $1.60 $5.32
Resistance Level $2.71 $6.48
Average True Range (ATR) 0.16 0.49
MACD 0.04 0.05
Stochastic Oscillator 73.91 49.12

Price Performance

Historical Comparison
ZVIA
VRCA

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: